12 November 2014
Merck Animal Health Launches ‘Creating Connections’ to Improve Cattle Well-Being
Program Helps Reduce Stress and Improve Health in Herds
SUMMIT, N.J, November 12, 2014 – Merck Animal Health (known as MSD Animal Health outside the USA and Canada) today announced the launch of Creating Connections, a new program designed to help producers better understand cattle behavior and use that knowledge to employ strategies that can reduce stress, improve reproduction and foster stronger immune responses. Since calmer cattle are easier to examine, diagnose, treat and move, the techniques shared through Creating Connections will help make it easier for producers to improve the health of their herds.
“At Merck Animal Health, we are committed to improving animal well-being and contributing to the ongoing success of our customers,” said Paulo Loureiro, D.V.M, Merck Animal Health. “We are proud to launch Creating Connections, a program that advances the health of cattle and creates value for our customers.”
The program will launch with a series of videos explaining how common cattle behavioral cues can be interpreted to understand their comfort and well-being. The video series will be followed by additional resources, including learning modules and training seminars, in the coming months.
“The behavior of cattle – how they interact with each other and with people – can be shaped by positive interactions with caregivers, and tell us a tremendous amount about how cattle are feeling,” said Tom Noffsinger, D.V.M., a consulting feedyard veterinarian well known for his work on low-stress cattle handling practices. “Creating Connections is a valuable tool to help producers all over the world improve herd health, as well as contribute to a safe environment for cattle and their handlers.”
To learn more about Creating Connections, ask your Merck Animal Health representative or visit www.creatingconnections.info.
About Merck Animal Health
Today's Merck is a global healthcare leader working to help the world be well. Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global animal health business unit of Merck. Through its commitment to the Science of Healthier Animals™, Merck Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.merck-animal-health.com or connect with us on LinkedIn and Twitter at @MerckAH.
Merck Forward-Looking Statement
This news release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Merck’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck’s 2013 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).